That's correct dist. Correct too Tana - I also would have hoped for more of a rise (or any rise!) after the phase 3 trial dosage announcement. Volume has been quite high though and I guess we forget that the share price not long ago was stuck around 8 and 9 cents. Its up over 30% form there. The partnering deal is all anyone wants to hear right now it seems. Fingers crossed.
Add to My Watchlist
What is My Watchlist?